130783-02-7 Usage
Uses
Used in Agrochemical Industry:
3,5-Bis(trifluoromethyl)benzenethiol is used as a key intermediate for the synthesis of various agrochemicals, such as pesticides and herbicides. Its unique chemical structure allows for the development of compounds with enhanced efficacy and selectivity in controlling pests and weeds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3,5-Bis(trifluoromethyl)benzenethiol is utilized as a building block for the development of new drugs. Its specific properties enable the creation of molecules with improved pharmacological profiles, potentially leading to more effective treatments for various diseases.
Used in Dyestuff Industry:
3,5-Bis(trifluoromethyl)benzenethiol is also employed in the dyestuff industry as a precursor for the production of various dyes. Its distinctive chemical structure contributes to the development of dyes with superior colorfastness and stability, making them suitable for a wide range of applications, including textiles, plastics, and printing inks.
Check Digit Verification of cas no
The CAS Registry Mumber 130783-02-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,7,8 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 130783-02:
(8*1)+(7*3)+(6*0)+(5*7)+(4*8)+(3*3)+(2*0)+(1*2)=107
107 % 10 = 7
So 130783-02-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H4F6S/c9-7(10,11)4-1-5(8(12,13)14)3-6(15)2-4/h1-3,15H/p-1
130783-02-7Relevant academic research and scientific papers
Solvent-free synthesis of thiophenol using uncatalyzed transfer hydrogenation
Zhou, Shaodong,Qian, Chao,Chen, Xinzhi
experimental part, p. 2432 - 2439 (2012/06/18)
Clean and sustainable transfer hydrogenation for aryl sulfonamides and sulfonyl chlorides is described. The protocol is chemoselective and uses neither catalyst nor solvent.
β-D-phenylthioxylosides, their method of preparation and their use as therapeutic agents
-
, (2008/06/13)
The present invention relates, by way of novel industrial products, to the β-D-phenylthioxyloside compounds of the formula STR1 in which: X represents a sulfur atom or an oxygen atom; R1, R2 and R3, which are identical or different, each represent a hydrogen atom, a nitro group, a cyano group, a group --CO--R (in which R represents a C1 -C4 alkyl group or a trifluoromethyl group), an amino group, an acetamido group (NHCOCH3), a C1 -C4 alkoxy group, a trifluoromethyl group or a phenyl group substituted by one or more cyano, nitro or trifluoromethyl groups, it being possible for R1 and R2, taken together, to form, with the phenyl group to which they are bonded, a β-naphthalenyl group which is unsubstituted or substituted by one or more cyano, nitro or trifluoromethyl groups; and Y represents the hydrogen atom or an aliphatic acyl group. These compounds are useful as therapeutic agents, especially as venous antithrombotics.
